Evidence map›Paper›PMID 42703491›Full record

ReviewCureus2026

Gastrointestinal Microbiota Imbalance and Sensory Processing Dysregulation in Autism Spectrum Disorder: A Systematic Review.

Felicia T Bonner-Reid

Abstract readReview
In one paragraph

Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Felicia T Bonner-ReidMedicine and Surgery, University of Medical Sciences of Granma (Celia Sánchez Manduley), Manzanillo, CUB.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by challenges with social communication and repetitive behaviors. Many people with ASD also experience gastrointestinal symptoms and sensory processing dysfunction. New research has identified a potential role for microbial dysbiosis (imbalance of gut microbiota) in these comorbidities. This systematic review aimed to explore the links between gut microbiota composition, gastrointestinal symptoms, sensory processing differences, and dietary patterns in individuals with ASD, as well as the potential for a bidirectional relationship and dietary-based interventions targeting the microbiota. PubMed, Scopus, Web of Science, and Google Scholar were used to retrieve publications from 2011 to 2026, and a systematic review was conducted. Studies were chosen that examined gut microbiota, gastrointestinal symptoms, and sensory processing in people with ASD. Only intervention and observational studies were included. Many people with ASD reported gastrointestinal symptoms, sensory processing differences, restricted dietary patterns, and gut microbiota composition. However, the majority of studies included were cross-sectional, which does not allow for an inference of temporal direction or causality. The evidence indicates there may be a bidirectional relationship between gastrointestinal and sensory symptoms and microbial differences, and the sensory symptoms, food selectivity, food restriction, stool consistency, use of medication, and clinical characteristics may also affect the composition of the microbiota. Initial microbiome interventions had some potential for improvement in selected outcomes, but with limited confidence due to small sample sizes, heterogeneity in methods used, and potential for bias. The current evidence suggests that changes in the gut microbiota composition are associated with gastrointestinal symptoms, sensory dysregulation, and dietary patterns in ASD, but does not provide evidence to indicate that microbial dysbiosis is a primary mechanism. The possibility of reverse causation exists, as the food environment could be influenced by sensory sensitivity and/or eating habits, and, in turn, these factors could affect the composition of the microbiota. To better understand directionality and the efficacy of microbiome-targeted interventions, longitudinal studies and sufficiently powered randomized controlled trials are warranted.

Indexed as

autism spectrum disordergastrointestinal microbiotamicrobial dysbiosisneurodevelopmental disordersensory dysregulation

Identifiers

PMID42703491
PMCPMC13546802

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.